---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-039836"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T12:48:30.682480+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# AIM Immunotech presents ovarian cancer chemoimmunotherapy data at SITC 2023

## Summary
- Poster presented at SITC 38th Annual Meeting (Nov 1-5, 2023) by UPMC collaborators.
- Data on combination intraperitoneal chemoimmunotherapy for recurrent platinum-sensitive ovarian cancer.
- Study demonstrates T-cell chemotactic locoregional response per poster title.
- Poster available on company's investor website.

## SEC filing metadata
- accession: 0001493152-23-039836
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315223039836/0001493152-23-039836-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315223039836/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-039836
- JSON: https://secwatch.observer/filing/0001493152-23-039836.json
- Plain text: https://secwatch.observer/filing/0001493152-23-039836.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.